Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Oakley

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
British Journal of Cancer|September 16, 2016
Response to 'Comment on 'The potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome''S M Robinson, D A Mann, D M Manas, et al.
Journal of Hepatology|April 30, 2013
Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy modelS M Robinson, J Mann, A Vasilaki, et al.
Toxicology Research|August 10, 2018
Pancreatic progenitor-derived hepatocytes are viable and functional in a 3D high density bioreactor culture systemM Richter, E A Fairhall, S A Hoffmann, et al.
Oncogene|February 9, 2016
A RelA(p65) Thr505 phospho-site mutation reveals an important mechanism regulating NF-κB-dependent liver regeneration and cancerA Moles, J A Butterworth, A Sanchez, et al.
Oncogene|October 4, 2011
BAG-1 interacts with the p50-p50 homodimeric NF-κB complex: implications for colorectal carcinogenesisS L Southern, T J Collard, B C Urban, et al.
Gut|March 18, 2006
Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated ratsM R Ebrahimkhani, S Kiani, F Oakley, et al.
JAMA|October 29, 1997
Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics SocietyG W Small, P V Rabins, P P Barry, et al.
Nature Communications|April 17, 2015
NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinomaC L Wilson, D Jurk, N Fullard, et al.
Nature Communications|September 22, 2015
Corrigendum: NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinomaC L Wilson, D Jurk, N Fullard, et al.
Autism : the International Journal of Research and Practice|October 12, 2023
Mapping the link between socio-economic factors, autistic traits and mental health across different settingsTeresa Del Bianco, Georgia Lockwood Estrin, Julian Tillmann, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
British Journal of Cancer|September 16, 2016
Response to 'Comment on 'The potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome''S M Robinson, D A Mann, D M Manas, et al.
Journal of Hepatology|April 30, 2013
Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy modelS M Robinson, J Mann, A Vasilaki, et al.
Toxicology Research|August 10, 2018
Pancreatic progenitor-derived hepatocytes are viable and functional in a 3D high density bioreactor culture systemM Richter, E A Fairhall, S A Hoffmann, et al.
Oncogene|February 9, 2016
A RelA(p65) Thr505 phospho-site mutation reveals an important mechanism regulating NF-κB-dependent liver regeneration and cancerA Moles, J A Butterworth, A Sanchez, et al.
Oncogene|October 4, 2011
BAG-1 interacts with the p50-p50 homodimeric NF-κB complex: implications for colorectal carcinogenesisS L Southern, T J Collard, B C Urban, et al.
Gut|March 18, 2006
Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated ratsM R Ebrahimkhani, S Kiani, F Oakley, et al.
JAMA|October 29, 1997
Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics SocietyG W Small, P V Rabins, P P Barry, et al.
Nature Communications|April 17, 2015
NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinomaC L Wilson, D Jurk, N Fullard, et al.
Nature Communications|September 22, 2015
Corrigendum: NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinomaC L Wilson, D Jurk, N Fullard, et al.
Autism : the International Journal of Research and Practice|October 12, 2023
Mapping the link between socio-economic factors, autistic traits and mental health across different settingsTeresa Del Bianco, Georgia Lockwood Estrin, Julian Tillmann, et al.
Pageof 4